The FARMAPRIM Pharmacovigilance Service collects and evaluates safety information received from patients, healthcare professionals, clinical studies, and scientific literature. Relevant safety data are assessed and reported to the competent regulatory authorities in accordance with applicable pharmacovigilance requirements.
The department continuously monitors the benefit-risk balance of medicinal products and contributes to the ongoing evaluation of their safety profiles, supporting the safe and effective use of medicines.
safety@farmaprim.md
(+373) 79-400-174
(+373 22) 28-18-45